| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
24,324 |
22,713 |
$781K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,211 |
9,544 |
$455K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
20,567 |
8,884 |
$215K |
| 87428 |
|
4,029 |
3,897 |
$193K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,212 |
2,159 |
$153K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,855 |
1,836 |
$140K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,861 |
1,765 |
$125K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
845 |
832 |
$69K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,750 |
2,645 |
$34K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,314 |
2,648 |
$25K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
363 |
351 |
$14K |
| 99429 |
|
246 |
239 |
$7K |
| 90461 |
|
4,427 |
3,503 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
428 |
418 |
$4K |
| 87400 |
|
398 |
197 |
$4K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
119 |
112 |
$2K |
| 99000 |
|
356 |
347 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
91 |
89 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
290 |
134 |
$1K |
| 96160 |
|
893 |
764 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
121 |
113 |
$750.72 |
| 97169 |
|
24 |
24 |
$690.00 |
| 87807 |
|
76 |
73 |
$587.58 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
95 |
92 |
$505.35 |
| 86403 |
|
116 |
107 |
$445.74 |
| 81002 |
|
306 |
297 |
$372.46 |
| 83655 |
|
51 |
50 |
$346.29 |
| 92552 |
|
29 |
29 |
$321.93 |
| 85018 |
|
247 |
241 |
$285.80 |
| CP002 |
|
14 |
13 |
$137.20 |
| 90686 |
|
2,175 |
2,116 |
$128.27 |
| 94760 |
|
1,190 |
1,090 |
$43.62 |
| 81003 |
|
19 |
18 |
$35.91 |
| A4208 |
Syringe with needle, sterile 3 cc, each |
127 |
68 |
$8.75 |
| 92551 |
|
531 |
525 |
$2.74 |
| 90619 |
|
69 |
67 |
$0.06 |
| 90677 |
|
715 |
694 |
$0.05 |
| 90656 |
|
535 |
515 |
$0.01 |
| 99173 |
|
616 |
613 |
$0.00 |
| 90670 |
|
546 |
521 |
$0.00 |
| 99072 |
|
2,860 |
2,623 |
$0.00 |
| 99051 |
|
1,106 |
1,049 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
26 |
26 |
$0.00 |
| 99177 |
|
905 |
898 |
$0.00 |
| 90633 |
|
291 |
280 |
$0.00 |
| 90715 |
|
25 |
25 |
$0.00 |
| 90700 |
|
57 |
57 |
$0.00 |
| 90648 |
|
153 |
151 |
$0.00 |
| 90710 |
|
43 |
43 |
$0.00 |
| 90707 |
|
53 |
51 |
$0.00 |
| 90697 |
|
371 |
354 |
$0.00 |
| 90698 |
|
69 |
67 |
$0.00 |
| 3008F |
|
4,514 |
4,477 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
132 |
127 |
$0.00 |
| 90680 |
|
396 |
382 |
$0.00 |
| 90716 |
|
40 |
39 |
$0.00 |
| 92558 |
|
56 |
56 |
$0.00 |
| 90651 |
|
125 |
121 |
$0.00 |
| 36416 |
|
48 |
47 |
$0.00 |
| A9150 |
Non-prescription drugs |
12 |
12 |
$0.00 |
| 90723 |
|
26 |
24 |
$0.00 |
| 90660 |
|
12 |
12 |
$0.00 |
| 90744 |
|
13 |
13 |
$0.00 |